These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37010772)

  • 21. Adverse Drug Reactions Spontaneously Reported at a Tertiary Care Hospital and Preventable Measures Implemented.
    Abu Esba LC; Al Mardawi G; AlJasser MI; Aljohani B; Abu Alburak A
    J Clin Pharm Ther; 2021 Apr; 46(2):460-469. PubMed ID: 33285001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands.
    van der Hooft CS; Sturkenboom MC; van Grootheest K; Kingma HJ; Stricker BH
    Drug Saf; 2006; 29(2):161-8. PubMed ID: 16454543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of adverse reactions to intravenously administered originator biologics in patients with rheumatoid arthritis: A 5-year retrospective study.
    Almalag HM; Alaujan SS; Alhazzani HS; Alzamel LA; Tashkandi RS; Alarfaj HF; Alarfaj AS; Omair MA
    Saudi Pharm J; 2022 Jul; 30(7):1044-1051. PubMed ID: 35903531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.
    Aagaard L; Strandell J; Melskens L; Petersen PS; Holme Hansen E
    Drug Saf; 2012 Dec; 35(12):1171-82. PubMed ID: 23072620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
    Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
    BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic review: hepatosplenic T-cell lymphoma on biologic therapy for inflammatory bowel disease, including data from the Food and Drug Administration Adverse Event Reporting System.
    Shah ED; Coburn ES; Nayyar A; Lee KJ; Koliani-Pace JL; Siegel CA
    Aliment Pharmacol Ther; 2020 Mar; 51(5):527-533. PubMed ID: 31990422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A patient-centred web-based adverse drug reaction reporting system identifies not yet labelled potential safety issues.
    Hasford J; Bruchmann F; Lutz M; Thürmann P; Schmiedl S
    Eur J Clin Pharmacol; 2021 Nov; 77(11):1697-1704. PubMed ID: 34143228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use and safety of anthroposophic medications in chronic disease: a 2-year prospective analysis.
    Hamre HJ; Witt CM; Glockmann A; Tröger W; Willich SN; Kiene H
    Drug Saf; 2006; 29(12):1173-89. PubMed ID: 17147463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of Biologics Approved for the Treatment of Rheumatoid Arthritis and Other Autoimmune Diseases: A Disproportionality Analysis from the FDA Adverse Event Reporting System (FAERS).
    Araujo AGS; Borba HHL; Tonin FS; Lenzi L; Venson R; Pontarolo R; Wiens A
    BioDrugs; 2018 Aug; 32(4):377-390. PubMed ID: 29873000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.
    Durrieu G; Palmaro A; Pourcel L; Caillet C; Faucher A; Jacquet A; Ouaret S; Perault-Pochat MC; Kreft-Jais C; Castot A; Lapeyre-Mestre M; Montastruc JL;
    Drug Saf; 2012 Oct; 35(10):845-54. PubMed ID: 22967189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007.
    Aagaard L; Weber CB; Hansen EH
    Drug Saf; 2010 Apr; 33(4):327-39. PubMed ID: 20297864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost of biologics per treated patient across immune-mediated inflammatory disease indications in a pharmacy benefit management setting: a retrospective cohort study.
    Wu N; Lee YC; Shah N; Harrison DJ
    Clin Ther; 2014 Aug; 36(8):1231-41, 1241.e1-3. PubMed ID: 25062652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surveillance of adverse drug reactions at an adverse drug reaction monitoring centre in Central India: a 7-year surveillance study.
    Sharma M; Baghel R; Thakur S; Adwal S
    BMJ Open; 2021 Oct; 11(10):e052737. PubMed ID: 34607871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database.
    Castillon G; Salvo F; Moride Y
    Drug Saf; 2019 Jan; 42(1):27-34. PubMed ID: 30121742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient Reporting of Adverse Drug Reactions (ADRs): Survey of Public Awareness and Predictors of Confidence to Report.
    Hariraj V; Aziz Z
    Ther Innov Regul Sci; 2018 Nov; 52(6):757-763. PubMed ID: 29714567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe adverse drug reactions to biological disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis in clinical practice.
    Leon L; Gomez A; Vadillo C; Pato E; Rodriguez-Rodriguez L; Jover JA; Abasolo L
    Clin Exp Rheumatol; 2018; 36(1):29-35. PubMed ID: 28598787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals.
    McLernon DJ; Bond CM; Hannaford PC; Watson MC; Lee AJ; Hazell L; Avery A;
    Drug Saf; 2010 Sep; 33(9):775-88. PubMed ID: 20701410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency of real-world reported adverse drug reactions in rheumatoid arthritis patients.
    Giraud EL; Jessurun NT; van Hunsel FPAM; van Puijenbroek EP; van Tubergen A; Ten Klooster PM; Vonkeman HE
    Expert Opin Drug Saf; 2020 Dec; 19(12):1617-1624. PubMed ID: 32990050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse Drug Reactions in Children: Comparison of Reports Collected in a Pharmacovigilance Project Versus Spontaneously Collected ADR Reports.
    Leitzen S; Dubrall D; Toni I; Stingl J; Christ P; Köberle U; Schmid M; Neubert A; Sachs B
    Paediatr Drugs; 2023 Mar; 25(2):203-215. PubMed ID: 36369590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.